Summary
Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins through its procellex plant cell-based protein expression system. The company’s product includes taliglucerase alfa or alfataliglicerase, which is a plant cell. It uses its procellex platform for developing a pipeline of proprietary, biosimilar and biobetter versions of recombinant therapeutic proteins, which is based on the plant cell-based expression technology. The company also conducts clinical research studies. It partners with other pharma companies to market its products. Protalix is headquartered in Carmiel, Israel.
Protalix BioTherapeutics, Inc. (PLX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 10
Pfizer And Protalix Biotherapeutics Enter Into Technology Transfer Agreement With Biomanguinhos 12
Equity Offering 13
Protalix BioTherapeutics to Raise USD10 Million in Private Placement of Shares 13
Protalix BioTherapeutics Completes Public Offering Of Common Stock For US$27 Million 14
Protalix BioTherapeutics Completes An Underwritten Public Offering For US$22 Million 16
Debt Offering 18
Protalix BioTherapeutics Completes Private Placement Of Notes Due 2018 For US$69 Million 18
Acquisition 20
Protalix BioTherapeutics Mulls Offering Itself For Sale 20
Protalix BioTherapeutics, Inc. - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Protalix BioTherapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Protalix Enters Into Technology Transfer Agreement With Oswaldo Cruz Foundation For Uplyso 10
Pfizer And Protalix Biotherapeutics Enter Into Technology Transfer Agreement With Biomanguinhos 12
Protalix BioTherapeutics to Raise USD10 Million in Private Placement of Shares 13
Protalix BioTherapeutics Completes Public Offering Of Common Stock For US$27 Million 14
Protalix BioTherapeutics Completes An Underwritten Public Offering For US$22 Million 16
Protalix BioTherapeutics Completes Private Placement Of Notes Due 2018 For US$69 Million 18
Protalix BioTherapeutics Mulls Offering Itself For Sale 20
Protalix BioTherapeutics, Inc., Key Competitors 21
Protalix BioTherapeutics, Inc., Key Employees 22
List of Figures
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Protalix BioTherapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8